28, Oct 2026
Sinopec Releases Africa Sustainability Report and Launches WE17 Global Communication Brand in Cairo

CAIRO, Oct. 28, 2026 /PRNewswire/ — China Petroleum & Chemical Corporation (HKG: 0386, “Sinopec” or “the Company”) released Sinopec’s Sustainability Report in Africa (2021-2025) in Cairo on October 25 which highlights five years of progress in energy cooperation, environmental protection, community development, and cultural exchange. The Company also introduced its global sustainability communication brand, WE17. The report shows that Sinopec implemented 33 projects across 16 African countries between 2021 and 2025, with cumulative investment exceeding US$5.7 billion and total tax payments and social responsibility contributions surpassing US$4 billion over the same period. In 2025, its operations directly created 16,000 local jobs.

Zhao Liuqing, Minister Counselor for Economic and Commercial Affairs at the Chinese Embassy in Egypt, addressed the event and noted that 2026 marks the 70th anniversary of diplomatic relations between China and Egypt and of the establishment of diplomatic relations between China and African countries. Mr. Zhao described Sinopec’s activities in Egypt as an example of the China-Egypt comprehensive strategic partnership and a contribution to stronger people-to-people ties. Magdy Amer, board member of the Egypt-China Friendship Association and former Egyptian ambassador to China, also delivered remarks recognizing Sinopec’s contributions to economic and social development.

Wei Dong, Managing Director of Sinopec Africa Office, presented the report and reaffirmed the Company’s commitment to leveraging its integrated industrial capabilities, increasing investment in quality resources, and balancing economic performance with ecological protection and community well-being. He also emphasized Sinopec’s continued participation in Africa’s industrialization and public service development.

Sinopec expands energy cooperation and environmental protection

The sustainability report documents Sinopec’s activities in oil and gas exploration, engineering services, refining, energy trade, and renewable energy. Sinopec is exploring wind and solar alternatives for oilfield operations in the Western Desert of Egypt through its partnership with Apache Corporation. At the Sinopec-Apache project in Egypt, gas flaring had been reduced by more than 60% by the end of 2025 through energy efficiency and gas recovery measures.

Additionally, Sinopec participates in five offshore exploration and development blocks in Angola and maintains long-term energy cooperation with Algeria. Its renewable energy activities include Ethiopia’s Adama Wind Power Project, which meets approximately 20% of the capital’s electricity demand, and a geothermal pipeline project that supports clean electricity generation in Kenya. Environmental initiatives include planting over 7,000 mangroves in Angola and deploying ultra-low-noise intelligent drilling rigs in Uganda which have reduced carbon emissions by more than 90% compared with conventional rigs.

Continued investment in communities and cultural exchange

Sinopec’s community programs focus on employment, vocational training, education, healthcare, and infrastructure. A welding training initiative in Uganda has equipped 60 local workers with internationally recognized certifications. Across Africa, the Company has helped with the construction of more than 70 water supply plants and installation of over 4,300 kilometers of water pipelines.

In Egypt, an education-assistance initiative has supported the construction of 201 girls’ schools, providing educational opportunities for over 15,000 students. Cultural exchange programs include the “Silk Road Book House – China Bookshelf” initiative in Egypt, Algeria, and Cameroon, as well as cultural exchange activities for young people.

Sinopec launches WE17

The event also saw the introduction of Sinopec’s global sustainability communication brand, WE17, under the slogan “Together for Better.” It is aligned with the United Nations’ 17 Sustainable Development Goals and focuses on the three themes of Clean, which represents environmental responsibility, Care, which emphasizes community well-being, and Culture, which promotes cross-cultural exchange.

Approximately 100 representatives from government, business, academia, and the media attended the event.

For more information, visit SINOPEC’s official website.

Sinopec Releases Africa Sustainability Report and Launches WE17 Global Communication Brand in Cairo

 

Logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/sinopec-releases-africa-sustainability-report-and-launches-we17-global-communication-brand-in-cairo-302921713.html

28, Oct 2026
CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets

SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ — CELSET INC., a Korean biotechnology company specializing in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to the international medical aesthetics industry.

 Soltox Botulinum Toxin Type A Brand package

SOLTOX is presented in 100 Unit and 200 Unit formulations with three defining technical characteristics: a 900 kDa toxin complex, a freeze dried dosage form, and an advanced purification process. Together, these attributes reflect a manufacturing approach emphasizing controlled processing, product characterization, and pharmaceutical quality.

The 900 kDa complex describes the molecular size of the botulinum toxin protein complex, including associated proteins. This characteristic identifies a specific formulation feature rather than establishing any claim of superior clinical duration or efficacy. SOLTOX is supplied as a lyophilized powder intended for reconstitution before administration by qualified medical professionals, in accordance with applicable product labeling and local requirements.

Purification forms another central element of the SOLTOX manufacturing approach. Advanced Botulinum Toxin Purification Technology is applied during the processing of botulinum toxin type A, with emphasis on separating the desired substance from unwanted materials. Production also involves controlled manufacturing conditions and botulinum toxin quality control procedures covering preparation, filling, freeze drying, and batch assessment.

CELSET highlights these manufacturing characteristics as the technical foundation of SOLTOX. Its product positioning draws attention to formulation identity and process controls without equating manufacturing characteristics with unverified differences in patient outcomes. The brand combines technical information with a concise identity designed for recognition throughout the medical aesthetics sector.

The launch establishes SOLTOX within CELSET’s international medical aesthetics activities. Its positioning reflects the growing visibility of Korean biotechnology and medical aesthetics manufacturing, alongside the importance of established medical channels and market specific regulatory frameworks. CELSET views country level market development and professional relationships as integral to the international presence of the SOLTOX brand.

SOLTOX’s introduction broadens CELSET’s medical aesthetics portfolio, complementing its focus on scientifically grounded product communication. The company emphasizes a consistent brand presentation and clear information for healthcare professionals across different markets. Availability and use are governed by the regulatory requirements applicable in each country.

About CELSET INC.

Based in Seoul, South Korea, CELSET INC. is a Korean biotechnology company focused on the medical aesthetics sector. SOLTOX reflects the company’s commitment to distinctive brands, aesthetic medicine manufacturing principles, and professional communication for the global aesthetics industry.

For inquiries: contact@celset.co.kr

Home Page : https://celset-aesthetics.com/

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/celset-launches-soltox-a-korean-botulinum-toxin-type-a-brand-for-international-markets-302921881.html

28, Oct 2026
Ozelle to Spotlight Scalable AI-Assisted Hematology with O-Cyte 1 at MEDICA 2026

O-Cyte 1 combines CBC testing and reviewable cell images with expandable throughput and service-ready design.

DÜSSELDORF, Germany, Oct. 28, 2026 /PRNewswire/ — As AI-assisted morphology becomes more integrated into routine hematology, laboratories need more than automated cell classification. Cell images must be available for professional review, while analyzers must also meet daily testing and maintenance requirements. At MEDICA 2026, Ozelle will spotlight O-Cyte 1, an automated hematology analyzer combining AI × CBM (Complete Blood Morphology) with scalable throughput and service-ready engineering.

Ozelle to Spotlight Scalable AI-Assisted Hematology with O-Cyte 1 at MEDICA 2026

The International Council for Standardization in Haematology (ICSH) approved a new digital morphology standardization project at its October 14–15 General Assembly. The initiative highlights the importance of verification, reproducibility and quality assurance in digital morphology.

O-Cyte 1 performs CBC testing with 7-part white blood cell differentiation, integrating high-resolution cell imaging and AI-assisted classification within the same analyzer. Cell images are linked to numerical results, allowing laboratory professionals to examine visual evidence when needed. This approach reflects Ozelle’s vision for the fourth generation of hematology analysis: making morphology intelligence more consistent, reviewable and scalable across routine hematology workflows.

To support everyday laboratory operation, O-Cyte 1 is designed for changing workloads and routine service needs. A standalone analyzer delivers up to 60 tests per hour, while a six-unit cascade reaches up to 360 tests per hour. Its integrated reagent kit and key fluid-contact components housed in consumables help simplify reagent handling and reduce routine maintenance. Built-in self-checks and replaceable modules support easier fault identification and servicing.

For IVD distributors, scalable configurations help serve laboratories with different testing volumes and provide a path for future capacity expansion. Simplified reagent management and modular design can also ease ongoing technical support and after-sales service.

At MEDICA, Ozelle will also feature EHBT-75, combining 7-diff hematology with cell imaging and morphology analysis, and EHBT-50, integrating hematology, immunoassay and dry biochemistry in a compact platform. Visitors can also explore Open Dx, Ozelle’s AI Workbench for AI-assisted report review and result sharing.

Meet Ozelle at MEDICA 2026, November 16–19, Hall 1, Booth D63, Messe Düsseldorf, to explore the systems firsthand and discuss distribution opportunities.

About Ozelle

Founded in Silicon Valley in 2014, Ozelle develops AI-powered hematology and integrated diagnostic systems for human and veterinary care. Its technology combines cell imaging and intelligent analysis in instruments designed for everyday clinical use.

www.ozellemed.com

info@ozellepoct.com

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ozelle-to-spotlight-scalable-ai-assisted-hematology-with-o-cyte-1-at-medica-2026-302920103.html

28, Oct 2026
Jiahui Launches International Cell Therapy Center to Expand Global Access to CAR-T Treatment

SHANGHAI, Oct. 28, 2026 /PRNewswire/ — Jiahui International Hospital launched Jiahui International Cell Therapy Center, building on landmark CAR-T cases and multidisciplinary expertise to serve patients from China and abroad.

The center was unveiled at the inaugural Jiahui International Cell Therapy Summit on October 23, hosted by Jiahui International Hospital and co-organized by Jiahui Medical Research & Education Group (J-Med). The event attracted livestream viewing registrations from 14 countries and regions.

Prof. HAO Siguo, Chief of Hematology at Jiahui International Cancer Center (JICC), and Prof. XUAN Linli, Chief of Medical Oncology at JICC, joined experts discussing cellular therapies for blood cancers, solid tumors and autoimmune diseases.

Eric J. Rubin, Editor-in-Chief of the New England Journal of Medicine (NEJM), noted that NEJM published one research article by Chinese scholars a decade ago, compared with more than 20 in 2026. Prof. John K. HSIANG, Chairman of Jiahui Health Executive Committee, highlighted China’s advances in medical innovation.

JICC has established a track record of pioneering CAR-T treatments and encouraging long-term patient outcomes. In September 2023, JICC treated China’s first international patient to receive axicabtagene ciloleucel (Axi-Cel) CAR-T therapy, a Singaporean woman with primary mediastinal large B-cell lymphoma, who remains relapse-free more than three years after treatment. Building on this milestone, JICC has provided CAR-T treatment to patients from Singapore, Hong Kong SAR, Russia, Hungary, New Zealand, India, Pakistan, the Maldives and other countries and regions. Following China’s June 2026 approval of Satri-cel (CT041), the world’s first CAR-T therapy approved for solid tumors, Jiahui became one of the first institutions to introduce it clinically and treated the world’s first international recipient—a 59-year-old New Zealand patient with advanced gastroduodenal cancer.

Prof. Allen WU, President of Jiahui International Hospital, said growing international demand helped drive the center’s launch. The hospital provides nearly 500,000 patient visits annually to people from 180 countries and regions. The new center will link research and clinical care through multidisciplinary expertise and international patient services.

Read the full story: https://jiahui.com/en/news/231

Contact Jiahui International Cancer Center:

Email: internationaloffice@jiahui.com

WhatsApp: +852 4619 1904

WeChat: Jiahui-GSN

Cision View original content:https://www.prnewswire.co.uk/news-releases/jiahui-launches-international-cell-therapy-center-to-expand-global-access-to-car-t-treatment-302921799.html

28, Oct 2026
Cavli Wireless Launches Cavli360, a Collaborative Industry Magazine Connecting the Global IoT Ecosystem

SAN JOSE, Calif., Oct. 28, 2026 /PRNewswire/ — Cavli Wireless, a global end-to-end IoT solutions provider, has launched the inaugural edition of Cavli360, a new industry publication featuring insights, experiences, and perspectives from across the connected technology landscape.

Officially launched at electronica India 2026 in Bengaluru, Cavli360 is a collaborative platform that brings together insights and perspectives from Cavli Wireless’s leadership team, customers, distributors, technology partners, industry experts, and analysts to spotlight innovations, industry developments, and emerging trends shaping the future of IoT.

Read Cavli360 Edition 1 online: Explore the digital magazine

Reflecting on nearly a decade of innovation and technological advancement, the inaugural edition of Cavli360 features insights from John Mathew, Founder and CEO of Cavli Wireless, on the company’s evolution, technological breakthroughs, and key milestones that have shaped its journey in the cellular IoT industry.

Perspectives from Cavli’s co-founders further shed light on the strategic and operational foundations that have supported the company’s growth over the years, while outlining its vision for the future.

Strategic Growth Highlights

  • Manufacturing expansion: Plans to triple manufacturing capacity.
  • International growth: Expanding beyond the Indian market to meet growing international demand.
  • Talent development: Shifting from talent acquisition toward nurturing talent and developing capabilities internally.

The magazine also brings together insights from Cavli’s leadership and functional teams, exploring the core capabilities behind its end-to-end IoT ecosystem. Covering hardware architecture, embedded firmware, RF engineering, quality assurance, manufacturing, customer support, and regulatory certifications, the articles highlight the depth of Cavli’s technical expertise and the engineering capabilities that drive its IoT innovations. Contributions from Cavli’s regional sales leaders provide insights into evolving market dynamics, changing customer requirements, and emerging opportunities across international markets.

Additionally, the publication provides a glimpse into Cavli’s end-to-end IoT ecosystem, highlighting its cellular IoT module portfolio, global connectivity powered by MNO/MVNO partnerships, and the Cavli Hubble™ platform that enables seamless connectivity management, remote device management, and lifecycle orchestration across IoT deployments. 

Technical and IoT Ecosystem Highlights

  • Engineering expertise: Hardware architecture, embedded firmware, RF engineering, quality assurance, manufacturing, customer support, and regulatory certifications.
  • Cellular IoT and connectivity: LPWAN, LTE, and 5G cellular IoT modules with integrated eSIM connectivity, powered by global MNO/MVNO partnerships for seamless cellular IoT connectivity.
  • Cavli Hubble™ platform: Connectivity management, remote device management, and lifecycle orchestration across IoT deployments.

Beyond internal perspectives, Cavli360 brings together insights from technology partners, distributors, customers, and industry analysts, offering a broader view of the developments shaping the cellular IoT ecosystem. Expert articles examine key industry trends, including 5G adoption in automotive applications, the convergence of AI and IoT, and the evolution from 5G to 6G. Customer success stories showcase real-world applications of Cavli’s integrated IoT solutions across smart retail, supply chain visibility, smart cities, and other sectors, highlighting their role in simplifying connectivity and enabling connected deployments. Technology partners and distributors also offer additional insights into emerging technologies, regional market dynamics, and growth opportunities across the global IoT landscape.

“IoT growth depends on collaboration across the entire ecosystem, from semiconductor providers and technology partners to device manufacturers and end users. Through Cavli360, we aim to bring these voices together and create meaningful conversations around the future of connectivity. We are excited to share insights into the latest developments and emerging trends shaping the IoT ecosystem through this inaugural edition and future editions of Cavli360,” remarked Alexander Johann Bufalino, CMO & VP of Cloud Services at Cavli Wireless.

Cavli360 Edition 1 is available digitally on the Cavli Wireless website, making it accessible to readers worldwide. Printed copies will also be distributed at various industry events and exhibitions attended by Cavli Wireless and its distribution partners. This includes the upcoming electronica Munich 2026, taking place from November 10–13, at the Trade Fair Center Messe München, Germany, where attendees can collect a copy from the Cavli Wireless Booth C2.628.

Through Cavli360, Cavli Wireless aims to foster a more connected, collaborative, and forward-looking IoT ecosystem, one where ideas spark innovation and shared knowledge drives progress. Cavli360 is more than a magazine; it is a platform for shaping conversations, inspiring innovation, and advancing the future of IoT together.

About Cavli Wireless

Cavli Wireless is a global end-to-end IoT solutions provider enabling organizations to build, deploy, and manage connected products at scale. Cavli’s integrated hardware-to-cloud ecosystem combines cellular IoT modules with built-in eSIM connectivity and Cavli Hubble™, a cloud-based platform for IoT connectivity, device and SIM lifecycle management.

Cavli enables OEMs, ODMs, enterprises, and technology partners to develop and scale connected solutions across automotive, industrial, and smart infrastructure applications through its integrated hardware, connectivity, and cloud capabilities.

Headquartered in the United States with engineering and operational capabilities across key markets, Cavli Wireless works with customers and partners worldwide to simplify connected product development and support scalable IoT deployments.

Mariam Abey George, Junior Associate – Digital Marketing

Cavli Wireless

mariam.george@cavliwireless.com

cavliwireless.com

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cavli-wireless-launches-cavli360-a-collaborative-industry-magazine-connecting-the-global-iot-ecosystem-302921807.html

28, Oct 2026
NxtGen Named an OpenAI Select Partner within the OpenAI Partner Network
  • Partnership to help customers translate AI adoption into measurable business outcomes
  • “SpeedCode” – a coding agent planned for engineering teams
  • Pilot to assess quality, completion time, and cost

BENGALURU, India, Oct. 28, 2026 /PRNewswire/ — NxtGen, a provider of cloud, AI infrastructure and managed services in India, today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network.

NxtGen | OpenAI Select Partner

The OpenAI Partner Network is a global programme for partners to build, sell and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities and customer relationships while equipping them with resources, enablement and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact.

Supporting Enterprise AI Adoption in India

As an OpenAI Select Partner, NxtGen will continue working with OpenAI to help organisations build, deploy and scale AI solutions responsibly and effectively.

This work will help organisations put GPT-6 Astra to work across more of their business, using deeper reasoning and computer use to complete complex workflows and deliver finished work. NxtGen will focus on supporting Indian enterprises with architecture, security, access controls, auditability and local operating support.

Speaking about the requirements of Indian enterprises, A S Rajgopal, MD & CEO, NxtGen, said, “India’s enterprises need access to advanced AI together with the governance, local operating capability and accountability required to put it to work.”

“Becoming an OpenAI Select Partner will help us bring these elements together and support customers as they move from experimentation to practical applications across their businesses,” he added.

Expanding AI Services and Introducing SpeedCode

NxtGen supports organisations in India with cloud, data centre, AI infrastructure, cyber resilience and managed services. Its AI services span discovery, architecture, evaluation, security review, adoption, usage governance and production operations.

NxtGen also plans to introduce SpeedCode, an India-focused, NxtGen-owned coding agent built using the open-source Codex CLI and OpenAI models via API. It is designed to help engineering teams turn defined software tasks into scoped, tested, and reviewable code changes while keeping developers in control.

Evaluating SpeedCode Through a Controlled Pilot

Looking ahead, NxtGen plans to offer a controlled SpeedCode pilot, enabling customers to assess accepted engineering work, completion time, quality, and cost before considering wider adoption. Through this work, NxtGen aims to help customers translate AI adoption into measurable business outcomes.

Learn more about the OpenAI Partner Network.

Also, for further information about NxtGen, please visit the website.

About NxtGen

NxtGen is India’s largest sovereign cloud provider, serving more than 1,000 customers across the country. NxtGen operates– SpeedCloud®- a public cloud platform, SpeedCloud Supreme – an alternative to private cloud and Industry vertical clouds for the Government and Financial Services. NxtGen delivers value to its customers by ensuring superior performance at lower cost. The NxtGen AI portfolio unifies GPU platforms from NVIDIA, AMD & Intel and provides a wide choice of highly optimised models to build enterprise use cases. NxtGen is working to truly democratise the cloud and AI technologies by making them viable for enterprises of all sizes.

For media queries, please reach out to marketing@nxtgen.com

 

NxtGen Cloud Technologies Private Limited Logo

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/nxtgen-named-an-openai-select-partner-within-the-openai-partner-network-302920766.html

28, Oct 2026
Kaizen Global Appoints Sivaramakrishnan Senthatty (Siva Sen) CEO of Kaizen Global India to Scale Global Delivery and Enterprise AI Capabilities

New leadership appointment strengthens Kaizen’s India GCC strategy, expanding global delivery, talent, and AI-driven transformation capabilities worldwide

ATLANTA and CHENNAI, India, Oct. 28, 2026 /PRNewswire/ — Kaizen Global LLC, a leading global provider of enterprise AI, data analytics, and technology services, today announced the appointment of Sivaramakrishnan Senthatty (Siva Sen) as Chief Executive Officer of Kaizen Global India. In this role, Siva Sen will lead the expansion of Kaizen’s India operations, strengthening its Global Capability Center (GCC) strategy to scale delivery, talent, and enterprise AI capabilities for clients worldwide.

Kaizen Gl

The appointment comes at a pivotal moment for Kaizen Global as it accelerates investments in its global delivery model. Kaizen Global India will serve as a core engine for enterprise transformation, leveraging Kaizen’s strengths in data engineering, advanced analytics, and enterprise AI, with continuous improvement and execution discipline.

Siva Sen brings extensive leadership experience in building and scaling global delivery organizations, with a strong track record of driving operational excellence, developing high-performing teams, and leading large-scale transformation initiatives. He joins Kaizen Global from LTM Ltd., an L&T Group Company, where he served as EVP and Country Head for Japan, leading international operations and market expansion. Prior to that, he held senior leadership positions at HCL Tech and TCS.

“As enterprises rethink how they build and scale capabilities in the AI era, the role of a high-quality global delivery hub becomes increasingly crucial,” said Krishna Arangode, Founder & CEO of Kaizen Global. “Siva Sen’s experience in building and operating large-scale delivery organizations will be critical as we shape Kaizen Global India into a differentiated engine for execution, innovation, and long-term client impact.”

Scaling a Next-Generation India GCC

Kaizen Global India is being designed as a high-impact global delivery hub, supporting enterprise clients across data, AI, ERP modernization, and innovation initiatives. The center will serve clients across key global markets, including India, Japan, the United States, Europe, and the Middle East.

Building on the recent acquisition of Nihon Technology, Kaizen Global India will leverage strong expertise in ERP implementations, cybersecurity, and application development and modernization, while expanding rapidly into advanced analytics and AI-led transformation capabilities.

Over the next few years, Kaizen Global plans to expand its India workforce across data engineering, AI/ML, ERP, and cybersecurity practice areas. This includes the building of specialized practice teams and investment in talent development, governance, and scalable delivery frameworks to support long-term growth.

Building a Global Delivery Engine for the AI Era

“What excited me about Kaizen Global is the opportunity to build a truly differentiated global delivery engine for the AI era,” said Siva Sen. “We’re bringing together strong data and AI capabilities with disciplined execution and a scalable delivery model. The focus in India will be on building high-quality teams and creating the operational backbone needed to deliver complex transformation programs with consistency and speed.”

“The industry is on the cusp of an AI-driven transformation that will redefine enterprise operating models,” said Anand Srinivasan, Chief Operating Officer and Managing Partner at Kaizen Global. “Organizations will need partners who can translate AI potential into real, scalable business outcomes. With Siva Sen leading our India operations, we’re building the capabilities needed to support that shift at scale.”

As Kaizen Global continues to expand its global footprint, the India center will play a key role in enabling closer alignment between strategy, technology, and execution. By building capabilities at scale and investing in talent and governance, Kaizen Global is positioning itself to support clients in navigating increasingly complex, AI-driven transformation journeys.

About Kaizen Global

Kaizen Global is a leading global provider of AI, data analytics, and technology services for enterprise transformation and business value generation. Combining business acumen with technical know-how, Kaizen Global delivers measurable, sustainable business outcomes through AI-enabled services, development of intelligent systems, and deployment of advanced analytics – all via a continuous improvement delivery model with a human-in-the-loop. Recognized for speed and flexibility by Gartner, NPR, Forbes, Entrepreneur, and by Inc. 5000 as one of America’s fastest-growing private companies, Kaizen is a certified minority-owned business headquartered in Atlanta with offices in New York, Dallas, Tokyo, Osaka, Chennai, and Hyderabad. Follow Kaizen Global on LinkedIn, Facebook, and Twitter @KaizenGlobal.com.

For more information, visit www.kaizenglobal.com.

Media Contacts:

Paulette Brown

Carabiner Communications

pbrown@carabinercomms.com 

770.577.3881

Prem Sivakumaran 

Growth Mechanics 

Prem@growthmechanics.in 

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/kaizen-global-appoints-sivaramakrishnan-senthatty-siva-sen-ceo-of-kaizen-global-india-to-scale-global-delivery-and-enterprise-ai-capabilities-302920196.html

27, Oct 2026
Ascendion Expands AI Advisory Community with Four Global Business and Technology Leaders

Former Global CTO of Banco Santander, former Group CIO of Currys, former CEO of IBPAP, and former Microsoft CVP and CTO of AI join the advisory community

Advisors will provide guidance on AAVA platform innovation, AI strategy, C-suite alignment, and enterprise adoption across Asia-Pacific, Europe, North America, and the UK

The growing community of advisors will bring practitioner perspective closer to Ascendion as enterprises move AI from experimentation to governed, production-scale outcomes

BASKING RIDGE, N.J., Oct. 27, 2026 /PRNewswire/ — Ascendion, an AI-native software engineering company, today announced the appointment of four global business and technology leaders to its AI Advisory Community: Andy Gamble, Jack Madrid, Julieta Ross, Ph.D., and Joseph Sirosh, Ph.D. 

Ascendion Expands AI Advisory Community with Four Global Business and Technology Leaders

The advisors bring perspectives rarely found in one group: executives who answered to Boards, regulators, and C-suites for what technology actually delivered; a builder of AI and data platforms at global scale; and a leader who shaped one of the world’s largest technology-services and talent ecosystems. Their experience spans banking, high-tech, media, and retail. Each will work directly with Ascendion’s regional and engineering leaders, so their counsel reaches the decisions it is meant to shape. 

“We are changing how software gets built. Enterprise leaders have moved past experiments. They want AI that delivers outcomes boards can measure and risk they can manage. Andy, Jack, Julieta, and Joseph have the experience and know where transformation succeeds. They will challenge our thinking, raise our ambition, and help us navigate a period of intense — and exciting — change,” said Karthik Krishnamurthy, CEO, Ascendion. 

Each advisor will map to a different part of the business, strengthening Ascendion’s alignment with leadership communities across the globe. 

  • Julieta Ross, Ph.D., former Global CTO of Banco Santander, brings two decades of leading technology inside global banks, along with public-company board experience. She will work with Ascendion’s leadership on executive relationships, go-to-market strategy, and growth, and will help the company meet the governance, regulatory, and risk expectations that banking and financial services leaders place on AI. 
  • Andy Gamble, former Group CIO of Currys plc, has spent nearly three decades as a technology buyer and transformation leader across consumer electronics, industrial, and retail businesses. He will advise Ascendion’s work across Europe and the UK, with a focus on consumer goods, manufacturing, and retail, and will share what executive teams and Boards expect from a technology partner. 
  • Joseph Sirosh, Ph.D., former Microsoft CVP and CTO of AI, has spent his career building and scaling machine learning platforms in the high-tech industry. He will advise Ascendion’s engineering leadership on the evolution of AAVA and its broader platform strategy as AAVA becomes an orchestration and harness layer for enterprise AI. 
  • Jack Madrid, former President and CEO of IBPAP, spent five years leading the industry association behind one of the world’s largest technology and business-services ecosystems, centered in the Philippines. He brings robust experience working across industries, including banking, high-tech, and media, and will advise Ascendion on Asia-Pacific markets and on how AI is reshaping global delivery, skills, and workforce models. 

Together, the advisors give Ascendion an outside perspective on the full spectrum of enterprise AI, from agentic platform strategy and product engineering to industry alignment and delivery. They will add capacity to Ascendion’s ongoing work on AI governance, helping ensure trusted impact from AI-native software engineering, and their practice-based insight will inform how Ascendion applies its Engineering to the Power of AI™ approach to commercial models, platform design, service execution, and workforce development. 

About Ascendion

Ascendion is a global AI-native software engineering company delivering trusted business outcomes – capital unlock, innovation velocity, lower risk – to 250+ enterprise clients. The company delivers business outcomes at scale by combining expert engineers, AI agents, and AAVA, Ascendion’s agentic AI platform. Together, they design, engineer, and operate production-ready software that improves everyday work and life. Learn more at www.ascendion.com.

Engineering to the Power of AI™, Engineering to Elevate Life™, and AAVA™ are trademarks or service marks of Ascendion. AAVA™ is pending registration. Unauthorized use is strictly prohibited.

Ascendion logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ascendion-expands-ai-advisory-community-with-four-global-business-and-technology-leaders-302921368.html

27, Oct 2026
Piramal Pharma Limited Announces Results for Q2 and H1 FY27

MUMBAI, India, Oct. 27, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026.

Consolidated Financial Highlights

(in ₹ Crores or as stated)

Particulars

Q2FY27

Q2FY26

YoY Growth

H1FY27

H1FY26

YoY Growth

Revenue from Operations

2,617

2,044

28 %

4,887

3,977

23 %

   CDMO

1,424

1,044

36 %

2,611

2,041

28 %

   CHG

849

644

32 %

1,592

1,281

24 %

   PCH

359

319

13 %

706

621

14 %

EBITDA

385

224

72 %

669

389

72 %

EBITDA Margin

14.7 %

11.0 %


13.7 %

9.8 %


PAT

5

(99)

105 %

(64)

(181)

64 %

Key Highlights

  • Broad-based Revenue Growth: Revenue grew 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
  • Significant Profitability Improvement: EBITDA increased 72% YoY in Q2FY27 and H1FY27, with over 350bps EBITDA margin expansion in both periods. This was driven by higher capacity utilization, operating leverage, disciplined execution, and sustained cost optimization initiatives.
  • Robust RFP Activity and Order Inflows: Added 22 new customers and successfully hosted 110 customer audits in H1FY27.
  • Best-in-Class Quality & Compliance: Successfully completed 12 regulatory inspections and 110 customer audits during H1FY27, while maintaining the Company’s track record of no Official Action Indicated classifications across US FDA inspections.
  • Upgrade FY27 Outlook: Based on the strong first-half performance and continued business momentum, we upgrade our FY27 outlook and now expect revenue growth of 19% to 20%, accompanied by meaningfully higher profitability.

Nandini Piramal, Chairperson, Piramal Pharma Limited said, “We delivered a strong H1FY27, with revenue growth of 23% and EBITDA margin expansion of over 350 basis points, driven by healthy demand across our businesses, disciplined execution, and improved operating leverage. The performance was led by our CDMO business, which grew 28% on the back of strong order inflows and robust execution. Our CHG business complemented this momentum with 24% growth, supported by inhalation anesthesia sales in ex-US markets and the integration of the Kenalog, while Consumer Healthcare continued to deliver steady 14% growth through the strong performance of Power Brands and e-commerce.

With H2 typically stronger than H1, we are well positioned to deliver a strong full-year performance, supported by a healthy order book, encouraging customer engagement, and continued operating discipline.”

Key Business Highlights

Contract Development and Manufacturing Organization (CDMO):

  • Robust Growth: Broad-based growth across India and overseas sites, supported by healthy commercial demand, improved execution and disciplined cost management. India and North America led performance across the network.
  • Enhanced Profitability: Better capacity utilization and operating leverage drove a meaningful improvement in profitability.
  • Strong Commercial Momentum: Strong RFP activity and order inflows resulted in addition of 22 new customers during H1FY27. Phase III pipeline increased to 28 molecules from 25 as of March 2026.
  • Innovation and On-Patent Revenue Growth: Innovation-related revenues grew 24%, while on-patent commercial manufacturing revenues grew 39% in H1FY27.
  • Differentiated Capabilities: Strengthened biologics capabilities through acquisition of a controlling stake in Yapan Bio. The Lexington expansion remains on track, will add sterile fill-finish capabilities, completing the integrated ADC offering. Commissioned a new microbiology laboratory at the site.
  • ADC Services continued to gain momentum, with revenues up 51% YoY in H1FY27.
  • Deepening Customer Engagement: Successfully hosted 110 customer audits during H1FY27, reflecting continued customer engagement and confidence in the Company’s quality systems.

Complex Hospital Generics (CHG):

  • Inhalation Anesthesia Leadership: Maintained leadership in the US Sevoflurane market with a 48% value share, while building traction in ex-US markets. (Source: IQVIA)
  • Kenalog® Integration: Kenalog® contributed to CHG revenue during Q2FY27 and is expected to be an important growth driver for the business in FY27.
  • Intrathecal Therapy: Maintained the #1 position in the US Intrathecal Baclofen market. (Source: IQVIA)
  • Injectable Pain Management: Continued collaboration with suppliers to ensure product availability.
  • Building a Differentiated and Specialty Portfolio: Continued investments in 505(b)(2) products, complex and differentiated generics, branded products, in-licensing and co-development to strengthen the long-term portfolio.

Piramal Consumer Healthcare (PCH):

  • Power Brands Continue to Outperform: Power Brands grew 21% YoY in H1FY27, contributing 53% of PCH sales, reflecting the strength of the core portfolio.
  • Strong E-commerce Momentum: Grew 32% YoY in H1FY27 and contributed 28% of PCH sales.
  • Innovation and Premiumization: Continued focus on fewer, larger, and higher-potential launches to enhance portfolio quality and margins. Launched the ‘Vizible’ range under Lacto Calamine to strengthen presence in premium skincare.
  • Sustained Brand Investments: Invested approximately 11% of PCH sales in media and trade promotion across digital and traditional channels to support long-term brand growth.
  • Bayer Distribution Agreement: The distribution agreement will naturally expire in December 2026. The transition is being jointly managed to ensure business continuity, with no material impact expected on FY27 guidance.

 

Consolidated Profit and Loss Statement

(in ₹ Crores or as stated)

Particulars

Quarterly

Half Yearly

Q2FY27

Q2FY26

YoY  Change

Q1FY26

QoQ  Change

H1FY27

H1FY26

YoY  Change

Revenue from Operations

2,617

2,044

28 %

2,270

15 %

4,887

3,977

23 %

Other Income

36

66

-45 %

89

(60) %

125

124

1 %

Total Income

2,653

2,109

26 %

2,359

12 %

5,012

4,101

22 %

Material Cost

906

703

29 %

852

6 %

1,758

1,397

26 %

Employee Expenses

714

611

17 %

676

6 %

1,390

1,230

13 %

Other Expenses

648

571

13 %

547

18 %

1,195

1,085

10 %

EBITDA

385

224

72 %

285

35 %

669

389

72 %

Interest Expenses

88

82

6 %

88

(1) %

176

169

4 %

Depreciation

233

203

15 %

224

4 %

457

400

14 %

Share of Net Profit of Associates

18

15

20 %

20

(9) %

37

33

12 %

Profit Before Tax

82

(46)

277 %

(7)

1,194 %

74

(146)

151 %

Tax

77

53

44 %

62

24 %

139

56

149 %

Net Profit after Tax

5

(99)

105 %

(69)

107 %

(64)

(202)

68 %

Exceptional item1

–

–

NA

–

NA

–

21

NA

Net Profit after Tax after Exceptional Item

5

(99)

105 %

(69)

107 %

(64)

(181)

64 %

  1. Exceptional items include, one time insolvency proceeds received from a claim filed against a third-party supplier of our complex hospital generics business, with the NCLT in November 2023

 

Consolidated Balance Sheet



(in ₹ Cr. or as stated)

   Key Balance Sheet Items

As at

30-Sep-26

31-Mar-26

Total Equity

8,165

8,162

Net Debt

4,859

4,164

Total

13,023

12,326




Net Fixed Assets

10,448

9,784

    Tangible Assets

4,923

4,843

    Intangible Assets including goodwill

4,254

3,841

    CWIP (including IAUD2)

1,271

1,100

Net Working Capital

2,260

2,081

Other Assets3

315

462

Total Assets

13,023

12,326

Earnings Conference Call

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 28th October 2026 from 10:00 AM to 10:45 AM (IST) to discuss its Q2 and H1 FY2027 Results.

The dial-in details for the call are as under:

Event

Location & Time

Telephone Number

Conference call on 28th October 2026

India – 10:00 AM IST

+91 22 6280 1461 / +91 22 7115 8320 (Primary Number)

1 800 120 1221 (Toll free number)

USA – 12:30 AM

(Eastern Time – New York)

Toll free number

18667462133

UK – 04:30 AM

(London Time)

Toll free number

08081011573

Singapore – 12:30 PM

(Singapore Time)

Toll free number

8001012045

Hong Kong – 12:30 PM

(Hong Kong Time)

Toll free number

800964448

Express Join with Diamond Pass™

Please use this link for prior registration to reduce wait time at the time of joining the call –Click here

About Piramal Pharma Limited:

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare (PCH) business, selling over-the-counter consumer and wellness products. In addition, one of PPL’s associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.

For more information, visit:  Piramal Pharma | LinkedIn

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/piramal-pharma-limited-announces-results-for-q2-and-h1-fy27-302921181.html

27, Oct 2026
etisalat achieves record 9M 2026 performance as consolidated net profit rises 46% YoY to AED 17.2 billion
  • Consolidated revenues for the first nine months of 2026 reached AED 57.6 billion, an increase of 10.0 per cent YoY
  • Consolidated net profit for the first nine months of 2026 reached AED 17.2 billion, up 45.9 per cent YoY
  • Group subscriber base reached 254.8 million
  • Group marks 50 years by taking the etisalat name forward into a new era of growth

ABU DHABI, UAE, Oct. 27, 2026 /PRNewswire/ — etisalat today announced its Q3 2026 consolidated financial results, reporting consolidated revenue of AED 19.5 billion, growing 6.9 per cent year-over-year (YoY). Consolidated revenues for the first nine months of 2026 reached AED 57.6 billion, up 10.0 per cent YoY. Consolidated net profit in Q3 reached 11.2 billion, while consolidated net profit for the first nine months of 2026 reached AED 17.2 billion, up 45.9 per cent YoY, reinforced by continued progress in building higher-value capabilities across connectivity, sovereign digital infrastructure and AI and by disciplined portfolio management.

etisalat GCEO Masood M.Sharif

In Q3, EBITDA rose by 5.1 per cent YoY, reaching AED 9.0 billion with a margin of 46.1 per cent. For the first nine months of 2026, EBITDA reached AED 26.7 billion, a growth of 10.3 per cent YoY, with a margin of 46.4 per cent.

etisalat’s total subscriber base reached 254.8 million in Q3 2026, representing 29.4 per cent YoY growth. In the UAE, subscribers rose 5.2 per cent YoY to 16.5 million, driven by strong demand for advanced digital services and intelligent connectivity. 

Financial Highlights


Q3 2025

Q3 2026

%Change

9M 2025

9M 2026

%Change

Consolidated Revenues

AED 18.2bn

AED 19.5bn

6.9 %

AED 52.4bn

AED 57.6bn

10.0 %

Consolidated Net Profit*

AED 3.0bn

AED 11.2bn

276.2 %

AED 11.8bn

AED 17.2bn

45.9 %

EBITDA

AED 8.5bn

AED 9.0bn

5.1 %

AED 24.2bn

AED 26.7bn

10.3 %

Earnings per Share

AED 0.34

AED 1.29

276.2 %

AED 1.36

AED 1.98

45.9 %

Total Group Subscribers

197.0 million

254.8 million

29.4 %

197.0 million

254.8 million

29.4 %

etisalat UAE Subscribers

15.7 million

16.5 million

5.2 %

15.7 million

16.5 million

5.2 %

  • Net Profit adjusted for Vodafone gain in Q3 2026 is AED 3.2bn and EPS AED 0.37
  • Net Profit adjusted for Vodafone gain in 9M 2026 is AED 9.2bn and EPS 1.06

The quarter also saw the completion of etisalat’s sale of its entire stake in Vodafone Group, generating total consideration of AED 21.9 billion, including the final dividend and gain of approximately AED 8.0 billion. The transaction contributed to the group’s financial performance during the quarter, providing additional financial flexibility.

As etisalat marks its 50th anniversary, it has set out a new vision to become a leading AI-powered and enabling telco and moved forward under the etisalat name, symbolising the central role of connectivity in the AI era. This ambition builds on the capabilities developed across digital services, cloud, cybersecurity, AI, infrastructure and fintech, bringing them into sharper focus around our strong telecommunications foundation with AI at its core.

Building on UAE’s ambition to become a global hub for advanced technology and AI, etisalat plans to expand its international connectivity capacity to more than 500 terabits per second (Tbps) by 2030, an increase of over twenty-five times of the current capacity, in addition to developing diverse routes designed to enhance connectivity efficiency and reliability, delivering advanced, low-latency performance. This reiterates the importance of the digital infrastructure as a fundamental pillar for supporting emerging technologies and enabling a knowledge-based, innovation-driven economy.

Masood M. Sharif Mahmood, Group CEO of etisalat, said: “Our performance in Q3 2026 underscores the resilience of our business model and the discipline with which we are turning growth opportunities into tangible results. Consolidated revenue reached AED 19.5 billion, an increase of 6.9 per cent YoY, while EBITDA reached AED 9.0 billion, up 5.1 per cent, with an EBITDA margin of 46.1 per cent. These results reflect the strength of our core connectivity business and the discipline of our execution. Combined with our focus, these strengths underpin our confidence in our ability to excel and create long-term value to our stakeholders”

Masood added: “Over the past several years, etisalat has built an integrated portfolio of broad range of advanced capabilities across AI, cloud computing, cybersecurity, digital services, and fintech. Today, as AI is integrated more deeply into core enterprise and government operations, the foundational connectivity, compute, and secure infrastructure powering it become more critical. With the group firmly establishing itself as a key enabler, we will continue to provide the secure digital infrastructure and ultra-fast connectivity that power this wide-reaching transformation.”

He continued: “This gives the etisalat brand, which means ‘communications’, a renewed purpose with a new and deeper meaning. Connectivity is no longer just about moving data, for us. It is about enabling the modern digital economy by building and operating the infrastructure and intelligent platforms that will define the future.”

Masood concluded: “etisalat has proven its ability to create sustainable value and to translate technological progress into direct, tangible commercial and economic impact. Building on decades of strategic achievements, enduring customer relationships, strong operational efficiency and infrastructure designed for maximum readiness and reliability, we remain focused on enabling the networks of the future, anchoring the region’s digital economies, and cementing the UAE’s position at the heart of the global digital economy.  As etisalat embarks on its next fifty years journey, we renew our commitment to build on the UAE leadership’s forward-looking vision and to continue investing with full confidence to compete and lead on the global scale.”

Contact

Nancy Sudheer

nsudheer@etisalat.ae 

etisalat achieves record 9M 2026 performance as consolidated net profit rises 46% YoY to AED 17.2 billion

etisalat Logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/etisalat-achieves-record-9m-2026-performance-as-consolidated-net-profit-rises-46-yoy-to-aed-17-2-billion-302921058.html